Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

The American College of Physicians issues new guidance on the prevention of episodic migraine with pharmacologic treatment recommendations.

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

Migraine is a recurrent and complex neurological disorder that can affect the quality of your life. Identifying triggers, ...

While over-the-counter medications often provide relief, natural remedies such as menthol are gaining popularity for their ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

Discover what your headache is telling you. Learn to identify and manage tension headaches, migraines, cluster headaches, and ...

How should she be evaluated and treated? What is the probable migraine type and the drug of choice for its treatment and long-term management?

Dr. Archelle Georgiou joined 5 EYEWITNESS NEWS on Wednesday to explain what's new in migraine research, treatment and prevention, as well as when you should see a neurologist.